Inventor · disambiguated record
Takahiro Matsuyama
Also filed as: MATSUYAMA TAKAHIRO
5 granted patents·2 pending applications·22 citations·filing 2004–2019
77Inventor score
Top patents by PatentIndex Score
7 records- 0189US10435379B2[4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 8, 2019·5 cites·9 claims
- 0289US10189796B2[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 29, 2019·6 cites·26 claims
- 0376US7591999B2Powdery preparation for nasal administrationMITSUBISHI TANABE PHARMA CORP·Filed 2004·Granted Sep 22, 2009·7 cites·17 claims
- 0470US8664221B2Method for treating an inflammatory disease by administering a 1,2,3,4- tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituentKATO MASATOMO·Filed 2009·Granted Mar 4, 2014·2 cites·8 claims
- 0566US8426406B2Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy groupKATO MASATOMO·Filed 2009·Granted Apr 23, 2013·2 cites·17 claims
- 0663US2019359577A1[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1h-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 0748US2014045842A1Method for treating an inflammatory disease by administering a 1,2,3,4-tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituentSANTEN PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Takahiro Matsuyama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →